In this study, we constructed a prognostic model using the RibGs, which could discriminate the outcome of each DLBCL patient regardless of IPI score, GCB or ABC and treatment of CHOP or R-CHOP. Here, DDIT3 is linked to diffuse large B-cell lymphoma.